Nobel İlaç Awarded Biotechnology Investment Award
Nobel İlaç closed the year 2021 with an award.
Nobel İlaç's investment in biotechnology was awarded in the 11th Golden Mortar Awards.
Our General Manager Oğuz Akandil and our Biotechnology Project and New Product Evaluation Director Hasan E. Zeytin received the award together.
Nobel İlaç Biotechnology Center was established to realize domestic manufacturing in the field of biotechnology and to develop new molecules.
On our campus, which will be the largest biotechnological pharmaceutical raw material manufacturing facility in Turkey with nearly a hundred employees who are experts in the field of biotechnology, the development studies of five strategically important molecules, including the Covid-19 vaccine, are carried out